To investigate whether the reduction in melanin content and tyrosinase activity in fisetin-treated human melanin-producing cells was associated with changes in key melanogenic enzymes, we analyzed the expression levels of MITF and tyrosinase in human melanoma cells treated with different concentrations of fisetin (0–40 μM) for 24 h. This evidence concerns the gene TYR and melanoma.